STOCK TITAN

Dyne Therapeutics, Inc. (DYN) Debt by Year

DYN

Dyne Therapeutics, Inc. carried $148.9M in long-term debt against $893.4M in cash and equivalents at the end of fiscal year 2025. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Dyne Therapeutics, Inc. has filed alongside them.

FY2025 annual
Long-Term Debt $148.9M
Cash & Equivalents $893.4M
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DYN Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY22DEF 14AFY2110-KFY2010-KFY1910-K
Long-Term Debt$148.9M$0N/AN/AN/AN/AN/A
Cash & Equivalents$893.4M+105.2%$435.4M+258.0%$121.6M-29.3%$172.1M-14.3%$200.8M-33.2%$300.9M+1956.1%$14.6M

DYN Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Long-Term Debt$199.3M+101.7%$149.4M$148.9M$99.1M$98.8MN/A$0N/AN/AN/AN/AN/A
Cash & Equivalents$676.1M+39.4%$753.1M+59.5%$893.4M+105.2%$573.6M+7.8%$485.0M-20.2%$472.3M+73.6%$435.4M+258.0%$532.2M+308.5%$608.2M+262.9%$272.0M+50.2%$121.6M-29.3%$130.3M-10.1%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Dyne Therapeutics, Inc. financials

Frequently Asked Questions

What was Dyne Therapeutics, Inc.'s long-term debt in fiscal year 2025?

Dyne Therapeutics, Inc. carried $148.9M in long-term debt against $893.4M in cash and equivalents at the end of fiscal year 2025.

What was Dyne Therapeutics, Inc.'s long-term debt in the most recent quarter?

Dyne Therapeutics, Inc. (DYN) reported $199.3M in long-term debt in Q2 2026. This represents an increase of 101.7% from the same quarter a year earlier.

What does long-term debt mean on a financial statement?

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Dyne Therapeutics, Inc. (DYN) reported on that line in every period on record.